Larvol Delta - SIENNA-A-Study-Investigating-Subcutaneously-Administered-Pozelimab-in-Combination-With-Cemdisiran-or-Cemdisiran-Alone-in-Adult-Participants-With-Geographic-Atrophy

cemdisiran (ALN-CC5) - Regeneron

Veopoz (pozelimab-bbfg) - Regeneron

http://clinicaltrials.gov/ct2/show/NCT06541704

Jul 30, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next